Ireland· IE-PA-EU/1/24/1827/001
FRUZAQLA 1 mg hard capsules
A fruquintinib product containing fruquintinib, registered in Ireland by Hutchmed Europe B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Fruquintinib is registered in 16 of 19 countries.
Countries holding a registration under ATC L01EK04 (fruquintinib), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Fruquintinib · ATC L01EK04
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fruquintinib costs, country by country.
Normalised to the WHO defined daily dose (3.75 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fruquintinib · price per daily dose (3.75 mg)
USD · FX 28 Sept 2026
- CH Switzerland$189.98
The record
At a glance
HPRA (Ireland)- Active substance
- Fruquintinib
- Manufacturer
- Hutchmed Europe B.V.
- Country
- Ireland (IE)
- ATC code
- L01EK04
- ATC class
- Fruquintinib
- Defined daily dose
- 3.75 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/24/1827/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fruquintinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFruzaqlaTakeda Pharmaceuticals America, Inc.
- CanadaFRUZAQLATAKEDA CANADA INC
- SwitzerlandFruzaqla
- CzechiaFRUZAQLATakeda Pharmaceuticals International AG Ireland Branch, Dublin
- SpainFRUZAQLA 1 MG CAPSULAS DURASTakeda Pharmaceuticals International Ag Ireland Branch
- FinlandFRUZAQLATakeda Pharmaceuticals International AG Ireland Branch
- FranceFRUZAQLA 1 mg, géluleTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- BelgiumFruzaqla 1 mgTakeda Pharmaceuticals International Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fruzaqla
- Liechtenstein · Fruzaqla
- Norway · Fruzaqla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/115bff11-bb0c-44ee-9048-3bdd3760844e GET /v1/drugs/115bff11-bb0c-44ee-9048-3bdd3760844e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L01EK04"
],
"strength": null,
"pa_number": "EU/1/24/1827/001",
"substances": [
"Fruquintinib"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "20/06/2024",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about fruquintinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.